Nevertheless, it is now well established that AXL expression is linked to increased risk of metastasis and poor survival in a variety of solid cancers including breast cancer, non-small cell lung carcinoma, ovarian cancer, and clear cell renal carcinoma [3,4,5,6,7,8]. This evidence concerns the gene AXL and breast carcinoma.